The Principal Investigator Award – UMDF 2026 Research Grant Program funds innovative research advancing the understanding, diagnosis, and treatment of primary mitochondrial disease.
Funder: United Mitochondrial Disease Foundation
Due Dates (Anticipated): March 2027 (Full application submission deadline, projected)
Funding Amounts: Up to $100,000 total over 2 years per award
Summary: Supports principal investigators conducting impactful research to advance understanding, diagnosis, and treatment of primary mitochondrial disease.
Key Information: No indirect costs allowed; PI salary support capped at 15% of award.
This award, part of the United Mitochondrial Disease Foundation (UMDF) Research Grant Program, provides up to $100,000 over two years to independent investigators leading innovative projects in primary mitochondrial disease (PMD). The goal is to fund high-impact research that advances knowledge, improves diagnosis, and enables the development of new treatments or potential cures for PMD. Proposals are welcome across all types of primary mitochondrial disease, with special interest in projects focused on mitochondrial fatty acid synthesis defects, single large-scale mitochondrial DNA deletions, and Leigh syndrome, though alignment with these areas is not required for eligibility.